Skip to main content
. 2014 Dec;88(24):14310–14325. doi: 10.1128/JVI.02428-14

TABLE 1.

Details of SIVmac251-infected pig-tailed macaques used in this studya

Study No. of macaques Vaccine ART Challengeb Outcome of vaccine Reference
1 11 Kunjin SIV No SIVmac251, intravenously No effect 29
2 31 Peptide immunotherapy (n = 21) or control (n = 10) Yesc SIVmac251, intravenously Immunotherapy effective 31
3 2 Influenza virus-SIV No SIVmac251, intrarectally No effect 30
a

A total of 44 macaques were studied.

b

The same stock of SIVmac251, supplied by R. Pal and N. Miller, was used for all infections.

c

The animals received ART from weeks 3 to 10 after infection.